Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer

Radiation: Drug target found for radioresistance Drugs that block the androgen receptor (AR) protein can help make radiation-resistant breast tumors susceptible to ionizing therapy. Corey Speers from the University of Michigan, Ann Arbor, USA, and colleagues characterized the radiation sensitivity o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Corey Speers, Shuang G. Zhao, Ben Chandler, Meilan Liu, Kari Wilder-Romans, Eric Olsen, Shyam Nyati, Cassandra Ritter, Prasanna G. Alluri, Vishal Kothari, Daniel F. Hayes, Theodore S. Lawrence, Daniel E. Spratt, Daniel R. Wahl, Lori J. Pierce, Felix Y. Feng
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/c2e0158317ef4f30b527bc09f5771091
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares